Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naïve population.
Perez-Iglesias R, Crespo-Facorro B, Martinez-Garcia O, Ramirez-Bonilla ML, Alvarez-Jimenez M, Pelayo-Teran JM, Garcia-Unzueta MT, Amado JA, Vazquez-Barquero JL. Perez-Iglesias R, et al. Schizophr Res. 2008 Feb;99(1-3):13-22. doi: 10.1016/j.schres.2007.10.022. Epub 2007 Dec 3. Schizophr Res. 2008. PMID: 18053689 Clinical Trial.
Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis.
Pérez-Iglesias R, Ortiz-Garcia de la Foz V, Martínez García O, Amado JA, Garcia-Unzueta MT, Ayesa-Arriola R, Suarez-Pinilla P, Tabares-Seisdedos R, Crespo-Facorro B. Pérez-Iglesias R, et al. Schizophr Res. 2014 Oct;159(1):90-4. doi: 10.1016/j.schres.2014.07.045. Epub 2014 Aug 20. Schizophr Res. 2014. PMID: 25151200 Clinical Trial.
Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
Crespo-Facorro B, Pelayo-Terán JM, Pérez-Iglesias R, Ramírez-Bonilla M, Martínez-García O, Pardo-García G, Vázquez-Barquero JL. Crespo-Facorro B, et al. J Psychiatr Res. 2007 Oct;41(8):659-66. doi: 10.1016/j.jpsychires.2006.05.002. Epub 2006 Jun 23. J Psychiatr Res. 2007. PMID: 16797591 Clinical Trial.
Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.
Alvarez-Jiménez M, González-Blanch C, Vázquez-Barquero JL, Pérez-Iglesias R, Martínez-García O, Pérez-Pardal T, Ramírez-Bonilla ML, Crespo-Facorro B. Alvarez-Jiménez M, et al. J Clin Psychiatry. 2006 Aug;67(8):1253-60. doi: 10.4088/jcp.v67n0812. J Clin Psychiatry. 2006. PMID: 16965204 Clinical Trial.
A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
Perez-Iglesias R, Crespo-Facorro B, Amado JA, Garcia-Unzueta MT, Ramirez-Bonilla ML, Gonzalez-Blanch C, Martinez-Garcia O, Vazquez-Barquero JL. Perez-Iglesias R, et al. J Clin Psychiatry. 2007 Nov;68(11):1733-40. doi: 10.4088/jcp.v68n1113. J Clin Psychiatry. 2007. PMID: 18052567 Clinical Trial.
51 results